Mary M. Horowitz

After formal education, Horowitz joined the International Bone Marrow Transplant Registry in 1985 and began serving as its Chief Scientific Director in 1991.^[3][4] While serving in this role, she was appointed Research Director for the Stem Cell Therapeutic Outcomes Database of the C.W. Bill Young Cell Transplantation Program and Principal Investigator of the Data and Coordinating Center of the National Blood and Marrow Transplant Clinical Trials Network.^[5] As a result of her mentorships, Horowitz was the recipient of the 2010 ASH Mentor Award in recognition of the "significant impact they have made in the training and career development of many physicians and scientists in the field of hematology."^[6] Horowitz continued to study the effectiveness of transplantation as a treatment for life-threatening diseases and was recognized by the American Society for Blood and Marrow Transplantation with the 2014 Lifetime Achievement Award.^[5]

In 2019, Horowitz earned recognition from the American College of Physicians and Aplastic Anemia & MDS International Foundation. During the summer of 2019, she received the 2019 Harriet P. Dustan Award for Science as Related to Medicine from the American College of Physicians.^[7] Later, Horowitz was honored by the Aplastic Anemia & MDS International Foundation "for the significant impact her work has had on stem cell transplant and hematologic malignancy practice worldwide."^[8]

• Mary M. Horowitz publications indexed by Google Scholar